Best Competitive Research Platforms for Acquisition Screening

Research-based guide · Sources checked 7 November 2026

An acquisition-screening platform should help a team find plausible targets and explain why they belong on a longlist. It should not turn incomplete private-company data into a false investment conclusion.

Verdict: evaluate Grata, Sourcescrub and Inven for private-company discovery and market-specific longlists. Add PitchBook when transaction and ownership context is central. Treat Dealroom or AlphaSense as complementary research candidates where their coverage answers a defined gap. Choose the system that makes exclusions, sources and uncertainty inspectable, not the one that returns the largest unexplained list.

This is a documentation-based workflow comparison. No target has been contacted, no valuation has been calculated, and no platform has been independently benchmarked for deal outcomes.

Define a screen that a researcher can explain

Start with the acquisition thesis: customer segment, geography, product capability, service model, company size and ownership constraints. Separate essential requirements from preferences.

For example, a buyer may require recurring software revenue, a specific integration capability and customers in a particular region. Those are different from a preferred headquarters location or a rough employee range.

Each condition needs a source and a confidence state. A website can support product capability; it may not support revenue quality. An estimated employee count should not silently become a hard financial qualification.

Make the output a research queue with reasons, not a final investment ranking. Screening narrows the universe. Legal, commercial, technical and financial diligence remain separate work.

Compare the platforms by their research role

PlatformDocumented starting pointBest evaluation useRequired proof
GrataPrivate-company and similar-company searchDiscovering businesses by operating characteristicsSource evidence behind inclusion and ownership filters
SourcescrubConnected sources and deal-sourcing workflowsExpanding a universe from industry sourcesProvenance, duplicate handling and current status
InvenCompany search and deal-search workflowsDescriptive search and ownership-aware filteringReproducible queries and transparent exclusions
PitchBookPrivate-company and transaction researchOwnership and deal contextCoverage and delivery rights for the selected population
Dealroom / AlphaSenseConditional complementary researchStartup ecosystem or document evidence gapsExact corpus and workflow fit

These are task-fit distinctions, not a measured ranking of accuracy. A platform can be excellent for one region or company type and weak for another.

Grata: test the operating-description match

Grata's data overview describes company and similar-company discovery for private-market research. Its market-insights material shows how a research question can lead to company lists.

That makes it a relevant candidate when industry codes are too broad and the acquisition thesis depends on what a business actually does.

Ask the vendor to explain why each of ten results matches the thesis. A similar-company result should expose supporting product or customer evidence, not merely a similarity score.

Then provide a near-match that must be excluded. A service provider that implements a product is not necessarily the product owner. A reseller, consultancy and software vendor may use nearly identical website language while having very different acquisition economics.

Sourcescrub: inspect source context and freshness

Sourcescrub's connected-sources product sheet describes linking companies to source context. Its buyer checklist discusses private-company discovery and sourcing requirements.

This is useful when industry guides, conferences and other source collections can reveal businesses missed by a simple keyword query.

A source appearance is still a lead, not proof of current operating fit. A company may have attended a conference years ago, discontinued a product or been acquired since the source was published.

Ask the vendor to distinguish the source date, collection date and latest company verification. Require an export that retains enough context to recheck a surprising result.

Inven: test descriptive search and deal context

Inven's company-search help describes searching by company characteristics and refining descriptive queries. Its deal-search guide discusses ownership and acquisition-related filtering.

That makes it worth evaluating when analysts need to move from a plain-language thesis to a longlist without relying exclusively on industry codes.

Keep the query reproducible. Record the exact description, filters, date and any manual exclusions. An AI-generated result list that changes without an explainable query state is difficult to review.

Ask what happens when a company has already been acquired or sits inside a sponsor's portfolio. The interface should help analysts inspect that state, but a consequential ownership conclusion still needs appropriate source verification.

PitchBook: transaction context rather than only discovery

PitchBook's deal-sourcing overview describes private-company and transaction research. It is a relevant addition where the screen depends on financing history, ownership or comparable transaction context.

Do not assume every privately held target has complete financial data. Ask the vendor to distinguish reported, estimated and unavailable values in both the interface and export.

PitchBook's API terms overview states that its API is a separate contracted offering. A researcher seat should not be treated as permission for unrestricted automated ingestion.

Use the platform to improve context and prioritize diligence. Do not infer that a database profile establishes seller willingness, a clean capitalization table or a defensible acquisition price.

Keep financial fields honest

Revenue, EBITDA, growth and ownership can come from filings, company statements, estimates or inference. Those are different evidence classes.

Retain the source type and effective date alongside the value. A precise-looking number without provenance should not receive more weight than a clearly stated unknown.

Employee counts can help identify rough scale, but they are not a universal revenue proxy. Services, software and manufacturing businesses have different labor economics, and contractor use can distort comparisons.

Avoid filtering out every unknown field. That can systematically remove bootstrapped or less-public businesses that may fit the thesis. Route uncertainty to research rather than treating it as proof of poor fit.

Design a useful reference set

Prepare known positives, known exclusions and ambiguous companies. Include a renamed business, an acquired product, a subsidiary, a regional specialist and a company whose website language overstates its actual product scope.

Give every platform the same thesis and reference set. Record discovery, false inclusion, entity matching and source availability separately.

A returned company should have a reason for inclusion. An excluded company should have a reason that a reviewer can challenge. That is more useful than a single vendor-generated relevance score.

Do not use the small pilot to claim a universal recall rate. It tests whether the workflow handles your recurring research difficulties, not whether it covers every possible private company.

Deduplicate at the business and product levels

A longlist can contain the same operating business under a legal name, trading brand, old domain and subsidiary. It can also contain several genuinely different businesses under a common parent.

Preserve those relationships rather than flattening them into one row or counting every domain as a separate target.

For a software thesis, identify whether the desired capability belongs to the company, a licensed third-party product or an acquired business unit. That distinction affects feasibility long before valuation begins.

Ask the platform to show an acquisition or rebrand correction. Your internal queue should update the existing target record while retaining the previous research history.

Make the analyst workflow reviewable

Every target should have a thesis-fit explanation, supporting sources, uncertainty list and next action. Keep machine-generated summaries separate from the underlying evidence.

A reviewer should be able to reject a target without deleting its history. Record why it was excluded and whether the reason is permanent or may change.

Assign research tasks narrowly: verify product ownership, confirm geography, inspect filings or investigate customer concentration. “Research this company” is too vague to create predictable progress.

Do not contact targets merely because they appeared in a platform. Outreach requires a separate approved process, appropriate contact handling and a clear relationship owner.

Export and integration requirements

Test whether the platform exports stable identifiers, source links, dates, ownership fields and analyst notes. A CSV containing only company names and domains is weak support for a durable research process.

Check CRM synchronization carefully. A stale import should not overwrite a newer human-verified ownership note. Define field authority and conflict handling before enabling automatic updates.

Retain the original provider record and your own adjudicated view separately. That makes later corrections understandable and avoids presenting internal inference as supplier data.

Ask about deletion, termination and licensing rights. The ability to export a field technically does not necessarily establish the right to retain or redistribute it indefinitely.

Price the full screening operation

No comparable all-in quote for these workflows was established from the official material reviewed here. Request pricing for the actual seats, company coverage, exports, integrations and support requirements.

Add analyst time, entity cleanup, source verification and CRM administration. A low seat price may not be economical if most results require manual repair.

If an API or data feed is required, quote it explicitly. Do not assume the browser subscription includes automated access, bulk history or redistribution.

Set a pilot budget and a decision rule before procurement. The aim is not to maximize the number of candidate companies; it is to reduce the cost of producing a defensible, relevant longlist.

An end-to-end acceptance exercise

Start with one narrow thesis and a fixed reference set. Search each platform, inspect the first results and record both matches and false positives.

Next ask a second analyst to reproduce five inclusion decisions from exported evidence. They should be able to distinguish a current product claim from an old marketing page or an estimate.

Introduce a changed ownership record and a duplicate brand. Confirm that the workflow preserves history and prevents duplicate outreach.

Finally, produce a short committee-ready screen with evidence limits. It should say which targets merit further diligence and why, not imply that the acquisition decision has already been made.

When not to buy a broad platform

A small founder-led acquisition search may begin with a narrow industry directory, public filings and a well-maintained research sheet. A broad platform is justified when discovery scale or data coordination becomes a real bottleneck.

Conversely, a complex corporate-development process may need several complementary sources. The answer is not necessarily one vendor with every possible feature.

Avoid buying software to compensate for an undefined thesis. If the team cannot explain a target's essential characteristics, more search results will mainly increase review work.

A platform earns its place when it improves a specific step: discovering overlooked firms, resolving entities, adding transaction context or making evidence review faster.

What this means for your team

Choose on the quality of the research handoff. The best result is a smaller, better-explained set of companies with clear uncertainties and next actions.

Keep the distinction between observed fact, provider estimate and internal inference visible through every export and summary.

Screening software can improve origination and research discipline. It cannot establish seller intent, transaction feasibility or investment merit on its own. Those conclusions require the appropriate evidence and qualified review.

Preserve negative findings

A rejected target can be valuable research. Retain the evidence and exclusion reason so the next sourcing cycle does not repeat the same investigation.

Separate a permanent thesis mismatch from a temporary uncertainty. A company outside the required geography may remain excluded, while unclear ownership may justify another check after a new filing. Neither state should disappear merely because a different analyst refreshes the longlist.

Use a separate review field for confidentiality and contact restrictions. A research record may be appropriate for internal screening while remaining unsuitable for broad distribution or automated outreach. Test that those restrictions survive export and CRM synchronization. Evidence quality and permission to reuse information are different controls, and both need an accountable owner before the workflow scales.

Related reading

FAQ

Is a screened target an investment recommendation? No. A screen identifies companies for further investigation. It does not establish valuation, seller intent or transaction suitability.

Can estimated revenue be used? It can be a clearly labeled research input. Preserve its source, date and uncertainty rather than presenting it as reported financial fact.

Should companies with missing data be excluded? Not automatically. Missing data can reflect limited disclosure. Use the acquisition thesis and risk requirements to decide what needs verification.

Does similar-company search prove commercial similarity? No. Inspect product, customer and operating evidence. Similar website language can conceal materially different business models.

What makes a platform worth buying? A reproducible improvement in discovery, entity resolution, evidence review or research coordination for your actual target population.